{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "20108654", "DateCompleted": {"Year": "2010", "Month": "03", "Day": "16"}, "DateRevised": {"Year": "2010", "Month": "01", "Day": "29"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1055/s-0031-1296457"], "Journal": {"ISSN": "0004-4172", "JournalIssue": {"Volume": "59", "Issue": "12", "PubDate": {"Year": "2009"}}, "Title": "Arzneimittel-Forschung", "ISOAbbreviation": "Arzneimittelforschung"}, "ArticleTitle": "Novel antitumor acetamide, pyrrole, pyrrolopyrimidine, thiocyanate, hydrazone, pyrazole, isothiocyanate and thiophene derivatives containing a biologically active pyrazole moiety.", "Pagination": {"StartPage": "666", "EndPage": "671", "MedlinePgn": "666-71"}, "Abstract": {"AbstractText": ["4-Amino-N-(1-phenyl-1H-pyrazol-5-yl)-benzenesulfonamide (sulfaphenazole) 1 was selected as strategic starting material for the synthesis of some novel acetamide 2, pyrrole 4, pyrrolo[2,3-d]pyrimidine 5, thiocyanate 6, hydrazone 7a,b pyrazole 8, isothiocyanate 9 and thiophene 12 derivatives to evaluate theantitumor activity. Compound 4 was more effective than the reference drug, doxorubicin (CAS 23214-92-8) as positive control."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center (MAPPRC), College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "Identifier": [], "LastName": "Alqasoumi", "ForeName": "Saleh I", "Initials": "SI"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ghorab", "ForeName": "Moustafa M", "Initials": "MM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ismail", "ForeName": "Zeinab H", "Initials": "ZH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Abdel-Gawad", "ForeName": "Soad M", "Initials": "SM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "El-Gaby", "ForeName": "Mohamed S A", "Initials": "MS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Aly", "ForeName": "Hala M", "Initials": "HM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Arzneimittelforschung", "NlmUniqueID": "0372660", "ISSNLinking": "0004-4172"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Indicators and Reagents"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrazoles"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Carcinoma, Ehrlich Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Indicators and Reagents"}, {"QualifierName": [], "DescriptorName": "Mass Spectrometry"}, {"QualifierName": ["chemical synthesis", "pharmacology"], "DescriptorName": "Pyrazoles"}, {"QualifierName": [], "DescriptorName": "Spectrophotometry, Infrared"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2010", "Month": "1", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "1", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "3", "Day": "17", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20108654", "10.1055/s-0031-1296457"]}}], "PubmedBookArticle": []}